AngioDynamics, Inc. (ANGO) vs CorMedix Inc. (CRMD)
A side-by-side comparison of AngioDynamics, Inc. and CorMedix Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ANGO
AngioDynamics, Inc.
$14.42HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
CRMD
CorMedix Inc.
$7.28HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — ANGO vs CRMD
growth of $100 · dividends reinvested · last 10yANGO -10.1% (-1.1%/yr)CRMD -48.3% (-6.4%/yr)ANGO compounded faster over this window
ANGO CRMD
ANGO vs CRMD: by the numbers
- •ANGO is the larger company ($596M vs $571M market cap).
- •CRMD is profitable (40.49% net margin) while ANGO runs a net loss (-11.48%).
- •CRMD grew revenue faster over the past five years (352.03% vs 1.93% CAGR).
Metrics side by side
Valuation
| Metric | ANGO | CRMD |
|---|---|---|
| P/E ratio | N/A | 3.42 |
| Forward P/E | N/A | 14.71 |
| P/S ratio | 1.86 | 1.24 |
| P/B ratio | 3.49 | 1.24 |
| EV / EBITDA | N/A | 1.82 |
| FCF yield | 0.09% | 43.82% |
Profitability
| Metric | ANGO | CRMD |
|---|---|---|
| Gross margin | 54.62% | 82.78% |
| Operating margin | -12.47% | 46.95% |
| Net margin | -11.48% | 40.49% |
| ROE | -21.51% | 40.62% |
| ROIC | -20.75% | 27.87% |
Growth (annualized)
| Metric | ANGO | CRMD |
|---|---|---|
| Revenue CAGR (5Y) | 1.93% | 352.03% |
| FCF CAGR (5Y) | -51.49% | N/A |
| Total return CAGR (5Y) | -10.80% | 9.70% |
Frequently asked
- Which has grown faster, ANGO or CRMD?
- Over the past five years, CRMD grew revenue faster — ANGO at a 1.93% CAGR versus CRMD at 352.03%.
- Is ANGO or CRMD more profitable?
- CRMD runs the higher net margin — ANGO at -11.48% versus CRMD at 40.49%.
- How have ANGO and CRMD total returns compared?
- Over the past 10 years, ANGO delivered -0.58% and CRMD delivered -7.74% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
CorMedix P/E ratioAngioDynamics ROECorMedix ROEAngioDynamics operating marginCorMedix operating marginAngioDynamics revenue growthCorMedix revenue growthAngioDynamics free cash flowCorMedix free cash flow
AngioDynamics & CorMedix appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.